Windtree Therapeutics
WINT
WINT was delisted on the 20th of August, 2025.
0 hedge funds and large institutions have $0 invested in Windtree Therapeutics in 2025 Q3 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 5 closing their positions.
0.46% less ownership
Funds ownership: 0.46% → 0% (-0.46%)
100% less funds holding
Funds holding: 5 → 0 (-5)
100% less capital invested
Capital invested by funds: $8.75K → $0 (-$8.75K)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 5
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Jane Street
New York
|
-$7.53K |
| 2 |
TRCT
Tower Research Capital (TRC)
New York
|
-$1.14K |
| 3 |
Bank of America
Charlotte,
North Carolina
|
-$53 |
| 4 |
SS
SBI Securities
Tokyo,
Japan
|
-$12 |
| 5 |
UBS Group
Zurich,
Switzerland
|
-$11 |
WINT Hedge Fund Activity: Q3 2025 in Review
0 of the 7,640 institutional investors tracked by Wall St. Rank reported a position in Windtree Therapeutics (WINT) for Q3 2025, worth a combined $0 — down 100% from $8.75K a quarter earlier.
Sellers outnumbered buyers: 5 funds closed out of WINT and 0 opened new positions — a net loss of 5 holders — while 0 trimmed existing stakes and 0 added.
The largest seller was Jane Street, exiting entirely with an estimated $7.53K sold.
- 0 institutional investors held Windtree Therapeutics (WINT) as of Q3 2025, down from 5 in Q2 2025.
- Funds reported $0 of Windtree Therapeutics stock for Q3 2025, down 100% quarter-over-quarter.
- 0 funds opened new Windtree Therapeutics positions in Q3 2025 and 5 closed out, a net change of -5 holders.
- The largest Windtree Therapeutics seller in Q3 2025 was Jane Street, an estimated $7.53K sold.
Based on aggregated 13F filings for Q3 2025.